Cargando…

Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival

BACKGROUND: Adjuvant radiotherapy (RT) following surgical resection confers a survival benefit for adult patients with locally advanced head and neck squamous cell carcinoma (HNSCC). We aim to investigate if adjuvant RT provides a similar survival advantage to patients ages 80+ through a national cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butkus, Joann M., Crippen, Meghan, Bar-Ad, Voichita, Luginbuhl, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562704/ https://www.ncbi.nlm.nih.gov/pubmed/36248977 http://dx.doi.org/10.3389/fonc.2022.973245

Ejemplares similares

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Manukian, Gregor, et al.
Publicado: (2019)

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
por: Johnson, Jennifer M, et al.
Publicado: (2023)

A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery
por: Rodin, Julianna, et al.
Publicado: (2018)

Single institution implementation of permanent (131)Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
por: Bar-Ad, Voichita, et al.
Publicado: (2019)

A nomogram to determine required seed air kerma strength in planar (131)Cesium permanent seed implant brachytherapy
por: Hubley, Emily, et al.
Publicado: (2019)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Luginbuhl, Adam, et al.
Publicado: (2021)

Audiometric Findings in Senior Adults of 80 Years and Older
por: De Raedemaeker, Kaat, et al.
Publicado: (2022)

Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base
por: Savard, Corey, et al.
Publicado: (2019)

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
por: Borson, Steven, et al.
Publicado: (2022)

eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy
por: Huang, Chung-I., et al.
Publicado: (2019)

Individualized elective irradiation of the clinically node‐negative neck in definitive radiotherapy for head and neck squamous cell carcinoma
por: Kou, Jia, et al.
Publicado: (2021)

A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2020)

Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Zheng, Haige, et al.
Publicado: (2021)

A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Huili, et al.
Publicado: (2022)

Characteristics of Atopic Bronchial Asthma in Seniors over 80 Years of Age
por: Bożek, Andrzej, et al.
Publicado: (2013)

Evaluation of Neo-Adjuvant, Concurrent and Adjuvant Chemotherapy in the Treatment of Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Akhlaghi, Fahimeh, et al.
Publicado: (2014)

The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma
por: Cierpikowski, Piotr, et al.
Publicado: (2023)

An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Liang, Yushan, et al.
Publicado: (2019)

Low expression of RalGAPs associates with the poorer overall survival of head and neck squamous cell carcinoma
por: Liu, Shan, et al.
Publicado: (2021)

A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Nindra, Udit, et al.
Publicado: (2023)

Adjuvant radiotherapy in high-risk cutaneous squamous cell cancer of the head and neck in immunosuppressed patients
por: Koyfman, Shlomo A., et al.
Publicado: (2015)

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
por: Haehl, Erik, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
por: Hanna, Glenn J., et al.
Publicado: (2022)

Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis
por: Black, Christopher M., et al.
Publicado: (2022)

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer
por: Tsai, Mu-Hung, et al.
Publicado: (2022)

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2016)

Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
por: Xu, Yuanyuan, et al.
Publicado: (2022)

Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017)

Adjuvant chemotherapy in head and neck cancer.
por: Stell, P. M., et al.
Publicado: (1990)

The Long Noncoding Transcript HNSCAT1 Activates KRT80 and Triggers Therapeutic Efficacy in Head and Neck Squamous Cell Carcinoma
por: Zhao, Yixuan, et al.
Publicado: (2022)

BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
por: Betzler, Annika C., et al.
Publicado: (2023)

Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience
por: Duru Birgi, Sumerya, et al.
Publicado: (2015)

Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Knops, Alexander M., et al.
Publicado: (2020)

Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Kumar, Ayan Tyagi, et al.
Publicado: (2019)

Combining Radiotherapy and Immunotherapy in Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Review of Current Clinical Trials
por: Plavc, Gaber, et al.
Publicado: (2020)

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2023)

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
por: Rühle, Alexander, et al.
Publicado: (2023)

Impact of age for overall survival in head and neck sarcoma
por: Suzuki, Hidenori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n1n2bq5pbbde9pmjrrt143s1uj